| |
| |
|
| Insider
Information: |
Pfizer Ventures (us) Llc |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
13,502,086 |
|
|
Indirect Shares
|
4,800,316 |
|
|
| Direct
Value |
$3,052,771 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,302,402 |
|
|
| Total
Value |
$3,052,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Springworks Therapeutics, Inc. |
SWTX |
10% Owner |
2019-09-17 |
4,593,847 |
2019-09-17 |
0 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2020-03-16 |
76,003 |
2020-03-16 |
1,481,719 |
Premium* |
|
|
Cortexyme, Inc. |
CRTX |
10% Owner |
2020-06-03 |
2,879,973 |
2020-06-03 |
0 |
Premium* |
|
|
Bioatla, Inc. |
BCAB |
10% Owner |
2020-12-18 |
0 |
2020-12-18 |
2,238,090 |
Premium* |
|
|
Pyxis Oncology, Inc. |
PYXS |
10% Owner |
2023-03-17 |
5,952,263 |
2023-03-17 |
1,080,507 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PYXS |
Pyxis Oncology, Inc. |
10% Owner |
– – • |
2023-03-17 |
4 |
B |
$2.76 |
$4,999,999 |
D/D |
1,811,594 |
5,952,263 |
2.45 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
10% Owner |
– – • |
2022-10-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,080,507 |
|
- |
|
| PYXS |
Pyxis Oncology, Inc. |
10% Owner |
– – • |
2022-10-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,140,669 |
|
- |
|
| BCAB |
Bioatla, Inc. |
10% Owner |
– – • |
2020-12-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,238,090 |
2,238,090 |
0 |
- |
|
| CRTX |
Cortexyme, Inc. |
10% Owner |
– – • |
2020-06-03 |
4 |
S |
$40.18 |
$14,866,600 |
D/D |
(370,000) |
2,879,973 |
0 |
% |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2020-03-16 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
1,481,719 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,169,219 |
1,169,219 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
76,003 |
76,003 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2019-09-17 |
4 |
B |
$18.00 |
$900,000 |
D/D |
50,000 |
4,593,847 |
2.45 |
- |
|
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2019-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,543,847 |
4,543,847 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
